Cargando…

Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy

BACKGROUND: The brain is a target for diabetic end-organ damage, though the pathophysiology of diabetic encephalopathy is still not well understood. The aim of the present study was to investigate the effect of diabetes on the metabolic profile of brain of patients having diabetes in comparison to h...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Sanjeev, Ekka, Meera, Sharma, Uma, P, Raghunandan, Pandey, R M, Jagannathan, N R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897881/
https://www.ncbi.nlm.nih.gov/pubmed/24433580
http://dx.doi.org/10.1186/1756-0500-7-41
_version_ 1782300313703677952
author Sinha, Sanjeev
Ekka, Meera
Sharma, Uma
P, Raghunandan
Pandey, R M
Jagannathan, N R
author_facet Sinha, Sanjeev
Ekka, Meera
Sharma, Uma
P, Raghunandan
Pandey, R M
Jagannathan, N R
author_sort Sinha, Sanjeev
collection PubMed
description BACKGROUND: The brain is a target for diabetic end-organ damage, though the pathophysiology of diabetic encephalopathy is still not well understood. The aim of the present study was to investigate the effect of diabetes on the metabolic profile of brain of patients having diabetes in comparison to healthy controls, using in-vivo magnetic resonance spectroscopy to get an insight into the pathophysiology of cerebral damages caused due to diabetes. METHODS: Single voxel proton magnetic resonance spectroscopy ((1)H-MRS) was performed at 1.5 T on right frontal, right parieto-temporal and right parieto-occipital white matter regions of the brain of 10 patients having type-2 diabetes along with 7 healthy controls. Absolute concentration of N-acetylaspartate (NAA), choline (cho), myo-inositol (mI), glutamate (Glu) and glutamine (Gln), creatine (Cr) and glucose were determined using the LC-Model and compared between the two groups. RESULTS: The concentration of N-acetylaspartate was significantly lower in the right frontal [4.35 ±0.69 vs. 5.23 ±0.74; p = 0.03] and right parieto-occipital region [5.44 ±0.52 vs.6.08 ±0.25; p = 0.02] of the brain of diabetics as compared to the control group. The concentrations of glutamate and glutamine were found to be significantly higher in the right frontal region of the brain [7.98 ±2.57 vs. 5.32 ±1.43; P = 0.01] in diabetics. Glucose levels were found significantly elevated in all the three regions of the brain in diabetics as compared to the control group. However, no significant changes in levels of choline, myo-inositol and creatine were observed in the three regions of the brain examined among the two groups. CONCLUSIONS: (1)H-MRS analysis indicates that type-2 diabetes mellitus may cause subtle changes in the metabolic profile of the brain. Decreased concentrations of NAA might be indicative of decreased neuronal viability in diabetics while elevated concentrations of Gln and Glu might be related to the fluid imbalance resulting from disruption of glucose homeostasis.
format Online
Article
Text
id pubmed-3897881
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38978812014-01-23 Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy Sinha, Sanjeev Ekka, Meera Sharma, Uma P, Raghunandan Pandey, R M Jagannathan, N R BMC Res Notes Research Article BACKGROUND: The brain is a target for diabetic end-organ damage, though the pathophysiology of diabetic encephalopathy is still not well understood. The aim of the present study was to investigate the effect of diabetes on the metabolic profile of brain of patients having diabetes in comparison to healthy controls, using in-vivo magnetic resonance spectroscopy to get an insight into the pathophysiology of cerebral damages caused due to diabetes. METHODS: Single voxel proton magnetic resonance spectroscopy ((1)H-MRS) was performed at 1.5 T on right frontal, right parieto-temporal and right parieto-occipital white matter regions of the brain of 10 patients having type-2 diabetes along with 7 healthy controls. Absolute concentration of N-acetylaspartate (NAA), choline (cho), myo-inositol (mI), glutamate (Glu) and glutamine (Gln), creatine (Cr) and glucose were determined using the LC-Model and compared between the two groups. RESULTS: The concentration of N-acetylaspartate was significantly lower in the right frontal [4.35 ±0.69 vs. 5.23 ±0.74; p = 0.03] and right parieto-occipital region [5.44 ±0.52 vs.6.08 ±0.25; p = 0.02] of the brain of diabetics as compared to the control group. The concentrations of glutamate and glutamine were found to be significantly higher in the right frontal region of the brain [7.98 ±2.57 vs. 5.32 ±1.43; P = 0.01] in diabetics. Glucose levels were found significantly elevated in all the three regions of the brain in diabetics as compared to the control group. However, no significant changes in levels of choline, myo-inositol and creatine were observed in the three regions of the brain examined among the two groups. CONCLUSIONS: (1)H-MRS analysis indicates that type-2 diabetes mellitus may cause subtle changes in the metabolic profile of the brain. Decreased concentrations of NAA might be indicative of decreased neuronal viability in diabetics while elevated concentrations of Gln and Glu might be related to the fluid imbalance resulting from disruption of glucose homeostasis. BioMed Central 2014-01-17 /pmc/articles/PMC3897881/ /pubmed/24433580 http://dx.doi.org/10.1186/1756-0500-7-41 Text en Copyright © 2014 Sinha et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sinha, Sanjeev
Ekka, Meera
Sharma, Uma
P, Raghunandan
Pandey, R M
Jagannathan, N R
Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy
title Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy
title_full Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy
title_fullStr Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy
title_full_unstemmed Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy
title_short Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy
title_sort assessment of changes in brain metabolites in indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897881/
https://www.ncbi.nlm.nih.gov/pubmed/24433580
http://dx.doi.org/10.1186/1756-0500-7-41
work_keys_str_mv AT sinhasanjeev assessmentofchangesinbrainmetabolitesinindianpatientswithtype2diabetesmellitususingprotonmagneticresonancespectroscopy
AT ekkameera assessmentofchangesinbrainmetabolitesinindianpatientswithtype2diabetesmellitususingprotonmagneticresonancespectroscopy
AT sharmauma assessmentofchangesinbrainmetabolitesinindianpatientswithtype2diabetesmellitususingprotonmagneticresonancespectroscopy
AT praghunandan assessmentofchangesinbrainmetabolitesinindianpatientswithtype2diabetesmellitususingprotonmagneticresonancespectroscopy
AT pandeyrm assessmentofchangesinbrainmetabolitesinindianpatientswithtype2diabetesmellitususingprotonmagneticresonancespectroscopy
AT jagannathannr assessmentofchangesinbrainmetabolitesinindianpatientswithtype2diabetesmellitususingprotonmagneticresonancespectroscopy